Pathological erythropoiesis with consequent anemia is a leading cause of symptomatic
morbidity in internal medicine. The etiologies of anemia are complex and include reactive as …

Erythropoiesis is a tightly-regulated and complex process originating in the bone marrow
from a multipotent stem cell and terminating in a mature, enucleated erythrocyte. Altered red …

Acute erythroleukemia is a rare form of acute myeloid leukemia recognized by its distinct
phenotypic attribute of erythroblastic proliferation. After a century of its descriptive history …

Identification of stage‐specific erythroid cells is critical for studies of normal and disordered
human erythropoiesis. While immunophenotypic strategies have previously been developed …

During the last decade, substantial advances have been made in the understanding of the
complex molecular, immunological and cellular disturbances involved in the initiation as …

Erythropoiesis is a process of enormous magnitude, with the average person generating two
to three million red cells every second. Erythroid progenitors start as large cells with large …

Anemia and transfusion need constitute major problems for patients with myelodysplastic
syndromes (MDS) and are associated with reduced quality of life, poorer survival and an …

Gene expression during terminal erythroid differentiation : Current Opinion in Hematology Gene
expression during terminal erythroid differentiation : Current Opinion in Hematology Log in or …

Characterization, regulation, and targeting of erythroid pro... : Current Opinion in
Hematology Characterization, regulation, and targeting of erythroid progenitors in normal …

The erythroid marrow and circulating red blood cells (RBCs) are the key components of the
human erythron. Abnormalities of the erythron that are responsible for anemia can be …